Literature DB >> 14706900

[The cost of radiotherapy].

P Martin1.   

Abstract

The higher human and material costs induced by the development of conformal radiotherapy and other innovative techniques have to be evaluated. Different studies reflect benefit for three-dimensional conformal radiation therapy. This needs appropriate economic analyses (cost/benefit, cost/utility). Conclusions from studies are rather in favour of new technics of radiotherapy when compared to standard technics and alternative therapeutic procedures and justify investments. The two cost accounting available in France are compared. Until now, medical reimbursements underestimate the costs related to treatment, slowing down implementation of new equipment and quality therapeutic practices. The mean reimbursement was 1,670 Euro always under mean real costs. To promote innovative treatments more rational reimbursement modalities are necessary. European experiences demonstrate than modern radiotherapy facilities don't induce expensive costs (average 3,800 Euro).

Entities:  

Mesh:

Year:  2003        PMID: 14706900

Source DB:  PubMed          Journal:  Bull Cancer        ISSN: 0007-4551            Impact factor:   1.276


  2 in total

1.  3D-CT implanted interstitial brachytherapy for T2b nasopharyngeal carcinoma.

Authors:  Yu-Feng Ren; Yuan-Hong Gao; Xin-Ping Cao; Wei-Jun Ye; Bin S Teh
Journal:  Radiat Oncol       Date:  2010-11-23       Impact factor: 3.481

2.  Difference in Restricted Mean Survival Time for Cost-Effectiveness Analysis Using Individual Patient Data Meta-Analysis: Evidence from a Case Study.

Authors:  Béranger Lueza; Audrey Mauguen; Jean-Pierre Pignon; Oliver Rivero-Arias; Julia Bonastre
Journal:  PLoS One       Date:  2016-03-09       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.